Omnicare Gets FCA Off-Label Prescription Action Trimmed

Law360, New York (May 20, 2013, 2:32 PM EDT) -- A Georgia federal judge on Friday trimmed several claims from a False Claims Act suit accusing Omnicare Inc. of charging Medicare for thousands of anti-psychotic drug prescriptions for off-label uses, ruling they weren't backed by evidence or were improperly added to an amended complaint.

According to U.S. District Judge William S. Duffey Jr., a “reverse” false claim allegation of relator Fox Rx Inc. —  a sponsor of Medicare Part D prescription drug plans — wasn’t authorized to be added to an amended complaint, and several of...
To view the full article, register now.